Related Experiment Video
Updated: Jul 10, 2026
06:43
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
Is there a relationship between myringosclerosis and atherosclerosis?
1Ankara Numune Education and Research Hospital, 4th ENT Clinic, Turkey. sadin27@yahoo.com
B-ENT
|November 1, 2007
Summary
This study found no significant relationship between atherosclerosis and myringosclerosis, despite their similar pathological processes. Further research is needed on plaque dimensions and bilateral involvement in myringosclerosis.
Area of Science:
- Otolaryngology
- Cardiology
- Pathophysiology
Background:
- Myringosclerosis and atherosclerosis share similar physiopathological mechanisms involving plaque formation.
- Previous literature has not adequately explored the potential relationship between these two distinct conditions.
- Both conditions arise from trauma to specific tissue layers: tympanic membrane for myringosclerosis and arterial intimal layer for atherosclerosis.
Purpose of the Study:
- To investigate the potential relationship between myringosclerosis and atherosclerosis.
- To compare the presence, dimensions, and bilaterality of myringosclerotic plaques in patients with and without atherosclerosis.
Main Methods:
- A cohort of 421 patients diagnosed with coronary artery disease was assessed.
- Atherosclerosis was evaluated using coronary angiography.
- Myringosclerosis was diagnosed via otoscopic examination.
Main Results:
- Of 316 patients with atherosclerosis, 20.5% also had myringosclerosis.
- Of 105 patients without atherosclerosis, 22.8% had myringosclerosis.
- No statistically significant relationship was found between atherosclerosis and myringosclerosis (p > 0.05). Plaque dimensions and bilateral involvement also showed no significant differences between groups.
Conclusions:
- There is no evidence of a shared genetic predisposition between atherosclerosis and myringosclerosis.
- This study is the first to address plaque dimensions and bilateral involvement in myringosclerosis.
- The findings suggest no direct relationship between atherosclerosis and myringosclerosis beyond their shared underlying pathological process of endothelial-epithelial damage.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...